π Guideline basis
Zoghbi WA, et al. Recommendations for Noninvasive Evaluation of Native Valvular Regurgitation (JASE 2017;30:303β71); 2025 ESC/EACTS Guidelines for the Management of Valvular Heart Disease (Eur Heart J 2025;46:4635β), including the revised asymptomatic intervention thresholds; British Society of Echocardiography 2025 practical guideline on aortic regurgitation.
Pathophysiology & Mechanisms
Aortic regurgitation imposes combined volume and pressure overload: the ventricle must eject the forward stroke volume plus the regurgitant volume, against systemic afterload. The critical variable is time.
Chronic AR
Progressive eccentric hypertrophy with sarcomere addition in series produces a large, compliant chamber. The ventricle accommodates a total stroke volume that may exceed 150 mL while maintaining a normal LVEDP. Wide pulse pressure, bounding peripheral pulses, and a long decrescendo murmur follow. Compensation can persist for decades; decompensation is insidious, and the ventricle that has begun to fail may be irrecoverable.
Acute severe AR β a different disease
The ventricle is normal-sized and non-compliant. The regurgitant volume enters a chamber that cannot dilate, so LVEDP rises abruptly toward aortic diastolic pressure. Four consequences follow, and each generates a specific echocardiographic sign:
- Premature (early) mitral valve closure β LV diastolic pressure exceeds LA pressure before the onset of ventricular systole, closing the mitral valve early. Visible on M-mode through the mitral valve.
- Diastolic mitral regurgitation β the LV-to-LA gradient reverses in late diastole, producing retrograde flow across a closed mitral valve on colour Doppler.
- Restrictive mitral inflow with a very short diastolic filling period β the transmitral gradient dissipates almost immediately.
- Collapse of forward output β tachycardia is the only available compensation, and it is a protective reflex, not an arrhythmia to be suppressed.
Critically, the classical severity signs are absent: pulse pressure is narrow rather than wide (aortic diastolic pressure falls while LVEDP rises, so the gradient and the murmur are brief and soft), the ventricle is not dilated, and the colour jet is short. The murmur may be inaudible. Acute severe AR is a lesion diagnosed by mechanism and physiology, not by jet size.
Aetiology and mechanism classification
Mechanism | Examples | Repair prospect |
Type I β normal cusp motion with root/annular dilatation or cusp perforation | Aortic root aneurysm, Marfan, bicuspid aortopathy, aortic dissection, endocarditis with perforation | Often repairable (root remodelling/reimplantation) |
Type II β cusp prolapse or flail | Bicuspid valve, myxomatous degeneration, endocarditis with cusp destruction, traumatic cusp avulsion | Often repairable |
Type III β cusp restriction | Rheumatic, calcific degeneration, radiation, post-valvuloplasty | Usually replacement |
In the ICU, three acute mechanisms dominate and each is a surgical emergency: type A aortic dissection extending into the root, infective endocarditis with cusp destruction or perforation, and iatrogenic AR after balloon aortic valvuloplasty or TAVI. Identifying the mechanism therefore matters more than grading the severity.
Diagnostic Synthesis
Severity parameters
Parameter | Mild | Moderate | Severe |
Vena contracta width, cm | < 0.3 | 0.3β0.6 | > 0.6 |
Jet width / LVOT width, % | < 25 | 25β64 | β₯ 65 |
Jet CW density and contour | Faint, incomplete | Dense | Dense, steep deceleration |
Pressure half-time, ms | > 500 | 200β500 | < 200 |
Descending aortic diastolic flow reversal | Absent or brief early | Intermediate | Holodiastolic, end-diastolic velocity β₯ 20 cm/s |
EROA, cmΒ² | < 0.10 | 0.10β0.29 | β₯ 0.30 |
Regurgitant volume, mL | < 30 | 30β59 | β₯ 60 |
Regurgitant fraction, % | < 30 | 30β49 | β₯ 50 |
LV size | Normal | Normal or mildly dilated | Dilated (chronic AR only) |
Interpreting the two most useful ICU parameters
Pressure half-time measures the rate at which the aorta-to-LV diastolic gradient dissipates. It shortens with severe regurgitation, but it also shortens with anything that raises LVEDP or lowers aortic diastolic pressure β a stiff ventricle, tachycardia, vasodilatation, or a coexisting lesion. In the ICU it is highly sensitive but not specific, and PHT < 200 ms should be read as "either severe AR or a non-compliant ventricle, probably both".
Holodiastolic flow reversal in the proximal descending aorta (suprasternal window, PW just distal to the left subclavian, end-diastolic velocity β₯ 20 cm/s) is comparatively specific for severe AR. Reversal extending into the abdominal aorta is more specific still. Note that a large arteriovenous fistula, a patent ductus, or a ruptured sinus of Valsalva can also produce diastolic runoff.
Acute severe AR β the diagnostic set
Finding | Mechanism |
Short pressure half-time (< 200 ms, often < 150) | Rapid pressure equalisation |
Premature mitral valve closure on M-mode | LVEDP exceeds LA pressure before systole |
Diastolic mitral regurgitation on colour | Reversed LVβLA gradient in late diastole |
Restrictive mitral inflow, very short filling period | Non-compliant ventricle |
Normal or near-normal LV cavity size | No time to remodel |
Tachycardia | Compensatory; shortens diastole and therefore regurgitant time |
Pulmonary oedema with a soft or absent murmur | The clinical trap |
ICU-Specific Limitations
Confounder | Effect | Response |
Tachycardia | Shortens diastole, reducing regurgitant volume; PHT harder to measure | Report heart rate; do not treat tachycardia in acute severe AR |
Vasodilatation / hypotension | Lowers the aorto-ventricular gradient; jet shrinks; severity under-called | Note MAP with the study |
Vasopressors | Raise aortic diastolic pressure and increase regurgitant volume | May worsen the patient while the "severity" appears higher |
Non-compliant LV (any cause) | Shortens PHT independently of AR severity | Corroborate with vena contracta and aortic flow reversal |
Eccentric jet | Jet width in the LVOT overestimates severity; wall-impinging jets underestimate | Vena contracta, ideally with 3D vena contracta area |
Coexisting mitral stenosis | AR jet contaminates mitral inflow, invalidating PHT-derived mitral valve area | Use planimetry for the mitral valve |
Severe AR + LVOT VTI | LVOT stroke volume = total, not forward, stroke volume | Use RVOT or mitral inflow for forward flow |
Therapeutic Logic
Chronic AR
Haemodynamic goals: fast, full and forward β the exact inverse of aortic stenosis.
- Avoid bradycardia. Longer diastole means more regurgitation. Target heart rate 80β100/min. Beta-blockade is generally counterproductive (with the specific exception of aortic dissection with AR, where the imperative to limit dP/dt takes precedence).
- Reduce afterload. Vasodilators reduce regurgitant fraction and increase forward output.
- Maintain preload for the dilated ventricle.
Acute severe AR
A surgical emergency. Medical therapy is a bridge measured in hours.
Intervention | Rationale |
Urgent surgical consultation | Definitive therapy; mortality is high with medical management alone |
Vasodilator (e.g. sodium nitroprusside) with careful pressure monitoring | Reduces regurgitant volume, increases forward output |
Inotropic support if required | Maintains forward flow |
Permit or maintain tachycardia | Shortens diastolic regurgitant time |
Intra-aortic balloon pump is absolutely contraindicated | Diastolic augmentation directly increases the regurgitant volume |
Avoid beta-blockers unless dissection dictates otherwise | Bradycardia increases regurgitant volume |
Cautious approach to positive-pressure ventilation | Can help pulmonary oedema, but reduced preload may worsen forward output |
Intervention thresholds
The 2025 ESC/EACTS guidelines retain surgery for symptomatic severe AR (I B) and for asymptomatic patients with LVEF β€ 50%, LVESD > 50 mm or LVESD indexed > 25 mm/mΒ² (I B), and add a Class IIb C recommendation extending consideration to asymptomatic patients with LVEF β€ 55%, indexed LVESD > 22 mm/mΒ², or indexed LVESV > 45 mL/mΒ² β a move toward earlier intervention driven by imaging-defined cardiac damage. ICU teams should record indexed LV dimensions and volumes so that these thresholds can be applied downstream.
π Critical pitfall: The absent murmur in acute severe AR. Rapid pressure equalisation makes the diastolic gradient brief and the murmur soft or inaudible. Pulmonary oedema with a normal-sized ventricle and an unremarkable-sounding heart is a classic presentation of a lesion requiring surgery within hours.
π Critical pitfall: Inserting an intra-aortic balloon pump in a hypotensive patient with undiagnosed acute severe AR. Diastolic augmentation drives blood retrograde into the ventricle and can be immediately fatal. Exclude significant AR before IABP insertion in every case.
π Critical pitfall: Treating compensatory tachycardia in acute severe AR. Slowing the heart lengthens diastole and increases regurgitant volume.
- π‘ Clinical pearl: In any hypotensive patient with a new diastolic murmur, chest or back pain, or a widened mediastinum, the AR is a dissection until proven otherwise. Image the root and arch, and escalate to TEE or CT immediately (Chapter 16).
- π‘ Clinical pearl: Premature mitral valve closure on M-mode is the most specific single sign of acute severe AR and takes seconds to obtain.
- π‘ Clinical pearl: Suprasternal PW Doppler for holodiastolic flow reversal is quick, is frequently omitted in ICU studies, and is the most specific readily obtainable severity marker.
References
- Zoghbi WA, Adams D, Bonow RO, et al. Recommendations for noninvasive evaluation of native valvular regurgitation. J Am Soc Echocardiogr 2017;30:303β71.
- ESC/EACTS. 2025 Guidelines for the management of valvular heart disease. Eur Heart J 2025;46:4635β.
- British Society of Echocardiography. Echocardiographic assessment of aortic regurgitation: a practical guideline. 2025.
- Lancellotti P, et al. Acute valvular heart disease. J Am Coll Cardiol 2021. PMID 34850332.
- Nagueh SF, Sanborn DY, Oh JK, et al. ASE 2025 diastolic function update (acute AR filling pressure indicators). J Am Soc Echocardiogr 2025;38:537β69.